(UPDATE) Niraparib
Mirvetuximab Soravtasine-gynx (Elahere)
Trametinib
Bevacizumab
Rivkin Center for Ovarian Cancer
ASCO: COVID-19 Medical Resources
Ovarian Cancer Research Fund Alliance
National Ovarian Cancer Coalition